ERIC ZUDAK, CEO
Eric has been working with clinical research teams since 2005, primarily focused on process engineering and technology for the education of Investigators and CRAs. During his time with Trifecta Clinical Eric worked across many therapeutic areas, leading the commercial implementation of enterprise solutions as the Account Director to a fortune 500 Pharma Sponsor. Eric also led client assessment and education programs for many of Trifecta’s portfolio customers, and implementation programs for a large device company as well as several small Biotech’s and CROs. In 2012 Eric led the OUS expansion, opening Trifecta’s first EU based sponsor account and later the first Asia PAC account in Japan.

After Trifecta was acquired by WCG, Eric was asked to serve as co-chair on the WCG Diversity, Equity and Inclusion Council, which he did proudly for 18 months until his departure. Eric counts the opportunity to learn from the DE&I community among the most significant of his career.

Since 2016, his work has been focused on projects related to endpoint assessments for clinical studies in the immuno-dermatology therapeutic area. Working with Sponsors, CROs and Medical Societies, Eric has supported a variety of endpoint measurement and validation projects. These projects include scale and instruction for Atopic Dermatitis, Generalized Pustular Psoriasis, Hand and Foot Syndrome, Hand Eczema, as well as adapting existing scales for used in assessing severity in skin of color.

In founding Thalocan, Eric hopes to improve the disease severity tools, processes, and data in the study of inflammatory skin disease for all stakeholders. The goal is to drive improved metrics for Sponsors, reduce the burden on trial investigators, and maximize the contribution of clinical trial volunteers.

Eric is a graduate of The University of Evansville school of Fine Arts.

CYRUS MIRAKHOR, COO

Take 12 years working in VP and Director level positions for California based startups with a specialty in remote collaboration and learning management. Add another 10 years working in telemedicine support at the National Institutes of Health for large scale imaging, web collaboration, and streaming media deployments. Then, put in a dash of filmmaking with a plethora of award-winning shorts and a feature film and what do you have? 

Someone who thinks it’s time to help revolutionize the way clinical trial efficacy assessment training is captured and delivered, that’s who!

After years working for startups in providing remote collaboration via private managed cloud deployments to Fortune 500 and Federal Government customers, followed by a little bit of AI work as it pertained to Amazon Alexa, Cyrus Mirakhor is happy to be back supporting those with medical research missions.

It was during his tenure in telemedicine as a Collaborations Architect for SAIC at the HHS/NIH that Cyrus found his work most meaningful. His past work includes managing one of the world’s first film-to-digital PACS/DICOM radiology department conversions, taking one of the federal government’s largest streaming media services Videocast.nih.gov from pilot to production, and deploying real time video and web collaboration services throughout the Federal Civilian and Military sectors.

He is honored to join Eric and the fabulous Thalocan team to support your clinical trial success! 

PAUL STROILI, VP CREATIVE
Paul began a career as a designer and creative consultant for Breakdown Services, Ltd, a company at the forefront of creating essential, industry-specific software and solutions to improve the audition and casting process for film, television and live theatre.  He founded Touchstone Graphic Design in 2010 and expanded to include marketing consultation as well as to provide services to clients outside of the entertainment industry.

Since then he has provided creative, design or consultation services to hundreds of clients, including Bally’s Las Vegas, Jim Beam Brands, California Charter School Association, Chevrolet, St. Paul’s Cathedral (San Diego), A World Fit for Kids, The Blume Group, Casting Society of America, Forever Living Products, Glavin Security Specialists, The TNS Group, Fort Raphael Publishing and Youthspeak Collective. He is also an artist in residence at Jeff Daniels’ Purple Rose Theatre in Chelsea, Michigan.

Paul attended the State University of New York at New Paltz and while a Los Angeles resident taught Fundamentals of Acting in the UCLA Extension program.  He is a published playwright and his writing has also appeared in Los Angeles Magazine and the Chicago Tribune.

He is honored to join forces with Eric and Cyrus to provide quality tools, support and trainings to improve the study and assessment of inflammatory skin diseases.